Untreated Adult Acute Lymphoblastic Leukemia Recruiting Phase 3 Trials for Beta-D-Glucose (DB02379)

Indication	Status	Phase
DBCOND0029290 (Untreated Adult Acute Lymphoblastic Leukemia)	Recruiting	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01406756	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	Treatment	Asparaginase Escherichia coli (DB00023) Beta-D-Glucose (DB02379) Calcium (DB01373) Clofarabine (DB00631) Cortisone (DB14681) Cyclophosphamide (DB00531) Cytarabine (DB00987) Dexamethasone (DB01234) Doxorubicin (DB00997) Ethanol (DB00898) Etoposide (DB00773) Hydrocortisone (DB00741) Hydrocortisone succinate (DB14545) Leucovorin (DB00650) Levoleucovorin (DB11596) Mercaptopurine (DB01033) Methopterin (DB16620) Methotrexate (DB00563) Pegaspargase (DB00059) Prednisone (DB00635) Sulfate ion (DB14546) Tioguanine (DB00352) Vincristine (DB00541)